The Pre-fillable syringe is specially designed to eliminate the withdrawal step and deliver the drug product directly to the patient, resulting in a more accurate drug dose with less exposure to needles. This syringe helps control the cost by minimizing overfill and reducing microbial contamination and medication dosing errors. The components of a pre-fillable syringe play an essential role in reducing contamination and handling problems. Stoppers, plungers, needle shields, rods, etc., are components of the syringe. Prefilled syringes are used for packaging injectable drugs and diluents. The drugs packaged in prefilled syringes are vaccines, blood stimulants, therapeutic proteins, erythroproteins, interferons, and rheumatoid arthritis. API of a combination product in continuous contact with the biologic drug, the plunger stopper plays a crucial role in determining the combination product's exposure to leachable and extractable. The European market for prefilled syringes is comparatively more mature than the US market.
The market's major driving factors are increasing demand for prefilled syringes, new requirements, and more sophisticated forms of drug delivery. Companies are collaborating on advanced developments in primary packaging and drug product interactions for more hygiene and accuracy, which is also responsible for the market's growth. Industrial investments are boosting the development and research regarding the finest syringes. In Dec 2020, BD announced the Investment of $1.2 Billion to upgrade the Pre-Fillable Syringe Manufacturing Capacity Over the Next Four Years. This investment includes a new manufacturing facility in Europe. In Feb 2022, West Pharmaceutical investing an additional $70M will add 70+ jobs in Kinston. The company's investment will enhance the production capacity, add warehouse and distribution space, and support the company's mission.
The limitations of the traditional medication administration technique include that it has unhygienic interactions, as well as interactions between prefilled syringes and the drug, which can cause stability concerns. The challenges for the prefilled syringe closures and accessories market are the safety system's low-cost alternative, and the requirement for more sophisticated forms of delivery as their requirements become more complex. Hence, the manufacturers need more significant investment to maintain competitiveness in the marketplace.
Global pre-fillable syringe closures and accessories market is segmented based on product and by end-user. Product segmentation is mainly devided into two subsegments: glass syringes, which consists of Plunger Stoppers, Plunger Rods, Backstops, Needle shields, Closure systems for luer lock syringes, Closure systems for luer cones syringes, Safety System/Component. Whereas polymer syringes include Plunger Stoppers, Plunger Rods, Backstops. End-user segmentation comprises Pharmaceutical & Biotechnology Companies, Contract Research & Manufacturing Organizations, Other Institutes. Global Pre-Fillable Syringe Closures and Accessories Market contains North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
Regionally Europe is likely to witness the market growth, followed by North America due to rapid investments and partnership programmes for minimizing production errors and innovative developments for low cost and more user-friendly designs.
Significant market players are BD (Becton, Dickinson and Company), Dätwyler Holding Inc., Gerresheimer AG, West Pharmaceutical Services, Inc., AptarGroup, Inc., Nipro PharmaPackaging International, Stevanato Group, Helvoet Rubber & Plastic Technologies BV, Nemera , chott AG, W. L. Gore & Associates, Inc., Owen Mumford Ltd, SANNER GMBH, and Other Prominent Player
Global Pre-Fillable Syringe Closures and Accessories Market, by End-user, 2022-2030 Value US$ Mn and Volume (No. of Units)
